2-21005955-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000384.3(APOB):​c.10913G>A​(p.Arg3638Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0841 in 1,613,688 control chromosomes in the GnomAD database, including 6,499 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R3638W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.066 ( 458 hom., cov: 32)
Exomes 𝑓: 0.086 ( 6041 hom. )

Consequence

APOB
NM_000384.3 missense

Scores

14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:18

Conservation

PhyloP100: 3.08

Publications

66 publications found
Variant links:
Genes affected
APOB (HGNC:603): (apolipoprotein B) This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins (LDL), and is the ligand for the LDL receptor. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. Mutations in this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, diseases affecting plasma cholesterol and apoB levels. [provided by RefSeq, Dec 2019]
APOB Gene-Disease associations (from GenCC):
  • hypercholesterolemia, autosomal dominant, type B
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • familial hypobetalipoproteinemia 1
    Inheritance: AR, AD, SD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017217398).
BP6
Variant 2-21005955-C-T is Benign according to our data. Variant chr2-21005955-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 128416.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0967 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000384.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOB
NM_000384.3
MANE Select
c.10913G>Ap.Arg3638Gln
missense
Exon 26 of 29NP_000375.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOB
ENST00000233242.5
TSL:1 MANE Select
c.10913G>Ap.Arg3638Gln
missense
Exon 26 of 29ENSP00000233242.1

Frequencies

GnomAD3 genomes
AF:
0.0655
AC:
9961
AN:
152046
Hom.:
456
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0235
Gnomad AMI
AF:
0.0164
Gnomad AMR
AF:
0.101
Gnomad ASJ
AF:
0.0536
Gnomad EAS
AF:
0.00116
Gnomad SAS
AF:
0.0224
Gnomad FIN
AF:
0.0693
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.0921
Gnomad OTH
AF:
0.0633
GnomAD2 exomes
AF:
0.0700
AC:
17541
AN:
250484
AF XY:
0.0686
show subpopulations
Gnomad AFR exome
AF:
0.0209
Gnomad AMR exome
AF:
0.0989
Gnomad ASJ exome
AF:
0.0502
Gnomad EAS exome
AF:
0.000327
Gnomad FIN exome
AF:
0.0715
Gnomad NFE exome
AF:
0.0924
Gnomad OTH exome
AF:
0.0788
GnomAD4 exome
AF:
0.0861
AC:
125770
AN:
1461524
Hom.:
6041
Cov.:
37
AF XY:
0.0838
AC XY:
60930
AN XY:
727038
show subpopulations
African (AFR)
AF:
0.0179
AC:
599
AN:
33466
American (AMR)
AF:
0.0977
AC:
4362
AN:
44630
Ashkenazi Jewish (ASJ)
AF:
0.0517
AC:
1351
AN:
26132
East Asian (EAS)
AF:
0.000227
AC:
9
AN:
39696
South Asian (SAS)
AF:
0.0264
AC:
2275
AN:
86236
European-Finnish (FIN)
AF:
0.0785
AC:
4188
AN:
53380
Middle Eastern (MID)
AF:
0.0470
AC:
271
AN:
5766
European-Non Finnish (NFE)
AF:
0.0972
AC:
108116
AN:
1111836
Other (OTH)
AF:
0.0762
AC:
4599
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
6921
13842
20762
27683
34604
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3884
7768
11652
15536
19420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0655
AC:
9968
AN:
152164
Hom.:
458
Cov.:
32
AF XY:
0.0635
AC XY:
4723
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.0234
AC:
973
AN:
41514
American (AMR)
AF:
0.101
AC:
1542
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.0536
AC:
186
AN:
3472
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5178
South Asian (SAS)
AF:
0.0228
AC:
110
AN:
4814
European-Finnish (FIN)
AF:
0.0693
AC:
734
AN:
10598
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0920
AC:
6259
AN:
67998
Other (OTH)
AF:
0.0632
AC:
133
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
464
927
1391
1854
2318
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
108
216
324
432
540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0822
Hom.:
2878
Bravo
AF:
0.0670
TwinsUK
AF:
0.107
AC:
395
ALSPAC
AF:
0.106
AC:
410
ESP6500AA
AF:
0.0225
AC:
99
ESP6500EA
AF:
0.0898
AC:
772
ExAC
AF:
0.0686
AC:
8330
Asia WGS
AF:
0.0170
AC:
60
AN:
3478
EpiCase
AF:
0.0943
EpiControl
AF:
0.0895

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
8
not specified (8)
-
-
3
Familial hypercholesterolemia (3)
-
-
2
Hypercholesterolemia, familial, 1 (2)
-
1
1
not provided (2)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Familial hypobetalipoproteinemia 1 (1)
-
-
1
Hypercholesterolemia, autosomal dominant, type B (1)
-
-
1
Hypercholesterolemia, autosomal dominant, type B;C4551990:Familial hypobetalipoproteinemia 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.81
T
BayesDel_noAF
Benign
-0.85
CADD
Benign
11
DANN
Benign
0.61
Eigen
Benign
-1.0
Eigen_PC
Benign
-0.77
FATHMM_MKL
Benign
0.15
N
MetaRNN
Benign
0.0017
T
MetaSVM
Benign
-1.0
T
PhyloP100
3.1
PrimateAI
Benign
0.18
T
PROVEAN
Benign
1.4
N
REVEL
Benign
0.11
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Vest4
0.051
MPC
0.040
ClinPred
0.0068
T
GERP RS
3.2
gMVP
0.20
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1801701; hg19: chr2-21228827; COSMIC: COSV51934384; API